NO179313C - Fremgangsmåte ved fremstilling av divalent vaksine virksom mot Pseudomonas aeruginosa - Google Patents
Fremgangsmåte ved fremstilling av divalent vaksine virksom mot Pseudomonas aeruginosaInfo
- Publication number
- NO179313C NO179313C NO893442A NO893442A NO179313C NO 179313 C NO179313 C NO 179313C NO 893442 A NO893442 A NO 893442A NO 893442 A NO893442 A NO 893442A NO 179313 C NO179313 C NO 179313C
- Authority
- NO
- Norway
- Prior art keywords
- pseudomonas aeruginosa
- against pseudomonas
- flagella
- effective against
- serotype
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 210000003495 flagella Anatomy 0.000 abstract 4
- 208000032536 Pseudomonas Infections Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000004899 motility Effects 0.000 abstract 1
- 210000001539 phagocyte Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0211388A AT390192B (de) | 1988-08-29 | 1988-08-29 | Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO893442D0 NO893442D0 (no) | 1989-08-28 |
| NO893442L NO893442L (no) | 1990-03-01 |
| NO179313B NO179313B (no) | 1996-06-10 |
| NO179313C true NO179313C (no) | 1996-09-18 |
Family
ID=3528050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO893442A NO179313C (no) | 1988-08-29 | 1989-08-28 | Fremgangsmåte ved fremstilling av divalent vaksine virksom mot Pseudomonas aeruginosa |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5324511A (ja) |
| EP (1) | EP0357585B1 (ja) |
| JP (1) | JPH0813752B2 (ja) |
| AT (2) | AT390192B (ja) |
| CA (1) | CA1302882C (ja) |
| DE (1) | DE58907391D1 (ja) |
| DK (1) | DK417689A (ja) |
| ES (1) | ES2055164T3 (ja) |
| FI (1) | FI95003C (ja) |
| NO (1) | NO179313C (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994008617A1 (en) * | 1992-10-16 | 1994-04-28 | Brigham And Women's Hospital, Inc. | O-derivatized alginic acid antigens |
| IL120202A (en) * | 1996-03-07 | 2001-03-19 | Akzo Nobel Nv | Container with freeze-dried vaccine components |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60248625A (ja) * | 1984-05-25 | 1985-12-09 | Mitsui Toatsu Chem Inc | 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途 |
| AT384032B (de) * | 1985-01-14 | 1987-09-25 | Immuno Ag | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) |
| US4693891A (en) * | 1985-09-09 | 1987-09-15 | Miles Laboratories, Inc. | Vaccine for Pseudomonas aeruginosa |
| AT391080B (de) * | 1986-06-24 | 1990-08-10 | Immuno Ag | Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen |
-
1988
- 1988-08-29 AT AT0211388A patent/AT390192B/de not_active IP Right Cessation
-
1989
- 1989-06-08 US US07/363,144 patent/US5324511A/en not_active Expired - Fee Related
- 1989-06-19 EP EP89890169A patent/EP0357585B1/de not_active Expired - Lifetime
- 1989-06-19 ES ES89890169T patent/ES2055164T3/es not_active Expired - Lifetime
- 1989-06-19 DE DE89890169T patent/DE58907391D1/de not_active Expired - Fee Related
- 1989-06-19 AT AT89890169T patent/ATE103817T1/de not_active IP Right Cessation
- 1989-08-24 DK DK417689A patent/DK417689A/da not_active Application Discontinuation
- 1989-08-28 NO NO893442A patent/NO179313C/no unknown
- 1989-08-28 CA CA000609542A patent/CA1302882C/en not_active Expired - Lifetime
- 1989-08-29 FI FI894048A patent/FI95003C/fi not_active IP Right Cessation
- 1989-08-29 JP JP1222778A patent/JPH0813752B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0357585B1 (de) | 1994-04-06 |
| NO893442L (no) | 1990-03-01 |
| ATA211388A (de) | 1989-09-15 |
| CA1302882C (en) | 1992-06-09 |
| US5324511A (en) | 1994-06-28 |
| FI95003B (fi) | 1995-08-31 |
| DK417689A (da) | 1990-03-01 |
| AT390192B (de) | 1990-03-26 |
| DK417689D0 (da) | 1989-08-24 |
| JPH02108634A (ja) | 1990-04-20 |
| ATE103817T1 (de) | 1994-04-15 |
| ES2055164T3 (es) | 1994-08-16 |
| EP0357585A2 (de) | 1990-03-07 |
| JPH0813752B2 (ja) | 1996-02-14 |
| EP0357585A3 (en) | 1990-04-25 |
| FI95003C (fi) | 1995-12-11 |
| NO179313B (no) | 1996-06-10 |
| NO893442D0 (no) | 1989-08-28 |
| DE58907391D1 (de) | 1994-05-11 |
| FI894048A0 (fi) | 1989-08-29 |
| FI894048A (fi) | 1990-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES500567A0 (es) | Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos. | |
| DE69409962D1 (de) | Immuntoleranzinduzierendes agens | |
| EP0822830A4 (en) | HUMAN ANTIBODIES FROM IMMUNIZED XENOMAS | |
| CA2033640A1 (en) | Vaccines against cancer and infectious diseases | |
| RU95105991A (ru) | Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации | |
| EP0306524A4 (en) | ANTI-DETERMINANTS DETECTED BY ANTIBODIES PRODUCED BY USING A RESTRICTED NUMBER OF ANTIGENT PRESENTING PATHOGENIC AGENTS OR DERIVATIVES. | |
| CA2022420A1 (en) | Escherichia coli vaccine | |
| CA2145397A1 (en) | Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines | |
| GR3029774T3 (en) | Method of preparing a radioactive rhenium complex solution. | |
| DK398683A (da) | Fremgangsmaade til fremstilling af antistoffer | |
| NO179313C (no) | Fremgangsmåte ved fremstilling av divalent vaksine virksom mot Pseudomonas aeruginosa | |
| EP0498804A4 (en) | A method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms | |
| AU2032988A (en) | A genus-specific listeria antigen identified by monoclonal antibodies | |
| PT760394E (pt) | Vacina de virus moderado da doenca de newcastle | |
| GB2227936A (en) | Vaccine against brucella abortus | |
| EP0328578A4 (en) | ANTIGEN IDENTIFIED BY MCA 16-88. | |
| EP0537168A4 (en) | Ctaa 28a32, the antigen recognized by mca 28a32 | |
| CA2133108A1 (en) | Pasteurella haemolytica type a-1 bacterin-toxoid vaccine | |
| BR9814556A (pt) | Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas | |
| EP0450573A3 (en) | Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections | |
| Zlakomanova et al. | THE PREVALENS OF PERTUSSIS IN CHILDREN IN CHELYABINSK 2007-2015 YEARS AND POSTVACCINAITION IMMUNITI AGAINST PERTUSSIS | |
| BOROWSKI | INTERACTION OF PSEUDOMONAS AERUGINOSA WITH HOST HUMORAL DEFENSE MECHANISMS (CYSTIC FIBROSIS) | |
| Lu et al. | Studies on the Immunological and Serological Identification of Spotted Fever Group Rickettsiae. | |
| DE3777196D1 (de) | Anti-parathyroid-antikoerper-praeparat. |